SCHEMBL30962736

SCHEMBL30962736

Cc1cc([N+](=O)[O-])ccc1C1=CCN(C)CCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 1/20 0.55
▸ ADAM10 O14672 1/20 0.44
▸ ERBB2 P04626 1/20 0.44
▸ ALDH1A1 P00352 5/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ TSHR P16473 1/20 0.43
▸ CYP3A4 P08684 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ HIF1A Q16665 1/20 0.40
▸ PAX8 Q06710 2/20 0.39
▸ RECQL P46063 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CRHBP P24387 1/20 0.39
▸ CRHR2 Q13324 1/20 0.39
▸ GAA P10253 2/20 0.38
▸ ACHE P22303 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL521746 0.92 SLC6A4 (0.63) SLC6A4ADAM10ERBB2ALDH1A1TDP1
SCHEMBL30912591 0.92 SLC6A4 (0.63) SLC6A4ADAM10ERBB2ALDH1A1TDP1
SCHEMBL30962789 0.84 ALDH1A1 (0.47) SLC6A4ADAM10ERBB2ALDH1A1TDP1
SCHEMBL17631252 0.80 SLC6A4 (0.46) SLC6A4ADAM10ERBB2ALDH1A1TDP1
SCHEMBL10036406 0.79 SLC6A4 (0.47) SLC6A4ADAM10ERBB2ALDH1A1TDP1
SCHEMBL10036445 0.78 ADAM10 (0.46) SLC6A4ADAM10ERBB2ALDH1A1TDP1
SCHEMBL30736527 0.78 SLC6A4 (0.62) SLC6A4ALDH1A1LMNA
SCHEMBL10036370 0.78 SLC6A4 (0.62) SLC6A4ALDH1A1LMNA
SCHEMBL30962763 0.78 SLC6A4 (0.62) SLC6A4ALDH1A1LMNAL3MBTL1RAB9A
SCHEMBL30962651 0.78 ALDH1A1 (0.48) ADAM10ERBB2ALDH1A1LMNAPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
Send feedback